Diagnostic Imaging Devices - Brunei Darussalam

  • Brunei Darussalam
  • The projected revenue in the Diagnostic Imaging Devices market market in Brunei Darussalam is expected to reach US$5.44m in 2024.
  • Looking ahead, the market is anticipated to grow at an annual growth rate (CAGR 2024-2029) of 3.56%, resulting in a market volume of US$6.48m by 2029.
  • In global comparison, the United States is expected to generate the highest revenue of US$11,930.00m in 2024.
  • Brunei Darussalam is experiencing a growing demand for state-of-the-art diagnostic imaging devices to enhance their healthcare system.

Key regions: Netherlands, China, Italy, Spain, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diagnostic Imaging Devices market in Brunei Darussalam is experiencing steady growth due to increasing customer preferences for advanced medical imaging technologies.

Customer preferences:
Customers in Brunei Darussalam are increasingly demanding high-quality and accurate diagnostic imaging devices. They prefer devices that offer faster and more precise imaging results, as well as those that are non-invasive and have minimal radiation exposure. This is driving the demand for advanced imaging technologies such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound devices.

Trends in the market:
One of the key trends in the Diagnostic Imaging Devices market in Brunei Darussalam is the adoption of digital imaging technologies. Digital imaging offers several advantages over traditional film-based imaging, including faster image acquisition, easier storage and retrieval of images, and the ability to enhance and manipulate images for better diagnosis. The shift towards digital imaging is driven by the need for improved efficiency and accuracy in diagnostic procedures. Another trend in the market is the increasing demand for portable and compact imaging devices. These devices are particularly useful in remote areas and for patients who are unable to travel to healthcare facilities. Portable ultrasound devices, for example, are being used in rural areas to provide quick and accurate diagnosis, especially in emergency situations.

Local special circumstances:
Brunei Darussalam has a small population and a relatively high per capita income. This means that the healthcare sector has the financial resources to invest in advanced medical technologies, including diagnostic imaging devices. The government of Brunei Darussalam has also been actively promoting healthcare development and investing in healthcare infrastructure, which further supports the growth of the Diagnostic Imaging Devices market.

Underlying macroeconomic factors:
The growth of the Diagnostic Imaging Devices market in Brunei Darussalam is also influenced by underlying macroeconomic factors. These include factors such as population growth, increasing healthcare expenditure, and advancements in medical technology. As the population grows and the healthcare needs of the population increase, there is a greater demand for diagnostic imaging devices. Additionally, advancements in medical technology, such as the development of more advanced imaging modalities, drive the demand for new and improved diagnostic imaging devices. In conclusion, the Diagnostic Imaging Devices market in Brunei Darussalam is growing due to increasing customer preferences for advanced medical imaging technologies. Customers in Brunei Darussalam are demanding high-quality and accurate diagnostic imaging devices, leading to the adoption of digital imaging technologies and the increasing demand for portable and compact imaging devices. The local special circumstances, such as the small population and high per capita income, along with the government's support for healthcare development, further contribute to the growth of the market. Additionally, underlying macroeconomic factors, such as population growth, increasing healthcare expenditure, and advancements in medical technology, drive the demand for diagnostic imaging devices in Brunei Darussalam.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)